CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

130 hedge funds and large institutions have $251M invested in Cymabay Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
-15
Holders Change %
-10.34%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
18
Increased
46
Reduced
34
Closed
32
Calls
$1.32M
Puts
$3.45M
Net Calls
-$2.13M
Net Calls Change
-$52K
Name Holding Trade Value Shares
Change
Shares
Change %
Rafferty Asset Management
151
Rafferty Asset Management
New York
-$98K -17,061 Closed
PAMU
152
Pictet Asset Management (UK)
United Kingdom
-$76K -13,200 Closed
Creative Planning
153
Creative Planning
Kansas
-$71K -12,449 Closed
Ohio Public Employees Retirement System (OPERS)
154
Ohio Public Employees Retirement System (OPERS)
Ohio
-$69K -11,958 Closed
AIM
155
Aigen Investment Management
New York
-$62K -10,785 Closed
PHK
156
Point72 Hong Kong
Hong Kong
-$57K -9,868 Closed
EAM
157
Eagle Asset Management
Florida
-$21K -3,867 Closed
US Bancorp
158
US Bancorp
Minnesota
-$8K -1,333 Closed
EW
159
Evoke Wealth
California
-$2K -333 Closed